Venn diagrams showed that targeting PD-1, PD-L1, and TIM-3 in breast cancer explants resulted in the upregulation or downregulation of common and distinct signaling pathways (Figure 5D,E). This evidence concerns the gene HAVCR2 and breast carcinoma.